Luminex Corporation

NASDAQ: LMNX · Real-Time Price · USD
36.99
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Luminex Revenue Breakdown

Period Ending Dec 31, 2013 Dec 31, 2012
Assays and Related Products Revenue 81.4M 81.55M
Assays and Related Products Revenue Growth -0.18% n/a
Technology and Strategic Partnerships Revenue 132.02M 121.03M
Technology and Strategic Partnerships Revenue Growth +9.08% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 39.1M 40.15M 37.78M 37.04M 36.79M 33.95M 34.3M 36M 34.34M 34.2M 28.51M 29.78M 28M 30.88M 28.62M 30.32M 26.35M 30.99M 28.88M 25.88M 21.99M 24.46M 22.01M 21.8M 20.38M
Selling, General, and Administrative Revenue Growth -2.60% +6.27% +2.00% +0.69% +8.36% -1.02% -4.72% +4.82% +0.41% +19.99% -4.27% +6.36% -9.35% +7.91% -5.60% +15.05% -14.96% +7.32% +11.58% +17.70% -10.13% +11.14% +0.97% +6.97% n/a
Research and Development Revenue 13.9M 13.8M 14.07M 13.86M 11.92M 12.93M 13.26M 14.98M 15.05M 13.17M 12M 11.67M 10.33M 10.37M 10.67M 12.26M 12.42M 13.34M 12.76M 11.54M 11.02M 10.94M 10.09M 11.51M 10.14M
Research and Development Revenue Growth +0.75% -1.98% +1.52% +16.32% -7.85% -2.48% -11.50% -0.42% +14.26% +9.79% +2.78% +13.04% -0.40% -2.84% -12.97% -1.29% -6.86% +4.49% +10.56% +4.76% +0.70% +8.41% -12.31% +13.45% n/a